• 1
    Hertog MGL, Fesken EJM, Hollman PCH, Katan MB, Kornhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Eldery Study. Lancet 1993; 0: 100711.
  • 2
    Keli SO, Hertog MGL, Feskens EJM, Krombout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch Intern Med 1996; 156: 63742.
  • 3
    Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52: 673751.
  • 4
    Soleas G, Diamandis EP, Goldberg DM. Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 1997; 11: 287313.
  • 5
    Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Fd Chem Toxic 1995; 33: 106180.
  • 6
    Benito S, Lopez D, Saiz MP, Buxaderas S, Sanchez J, Puig-Parellada P, Mitjavila MT. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol 2002; 135: 9106.
  • 7
    Singhal RL, Yeh YA, Praja N, Olah E, Sledge GW Jr, Weber G. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun 1995; 208: 42531.
  • 8
    Janssen K, Mensink RP, Cox FJJ, Harryvan JL, Hovenier R, Hollman PCH, Katan MB. Effect of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 1998; 67: 25562.
  • 9
    Yoshizumi M, Tsuchiya K, Kirima K, Kyaw M, Suzaki Y, Tamaki T. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated C-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol Pharmacol 2001; 60: 65665.
  • 10
    Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351: 95105.
  • 11
    Yap CL, Anderson KE, Hughan SC, Dopheide SM, Salem HH, Jackson SP. Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3). Blood 2002; 99: 1518.
  • 12
    Tzeng SH, Ko WC, Ko FN, Teng CM. Inhibition of platelet aggregation by some flavonoids. Thrombosis Res 1991; 64: 91100.
  • 13
    Pignatelli P, Pulcinelli F, Celestini A, Lenti L, Ghiselli A, Gazzaniga PP, Violi F. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nut 2000; 72: 11505.
  • 14
    Kelly C, Hunter K, Crosbie L, Gordon MJ, Dutta-Roy AK. Modulation of human platelet function by food flavonoids. Biochem Soc Trans 1996; 22: 197S.
  • 15
    Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 112132.
  • 16
    Rosing J, Van Rijn JLML, Bevers EM, Van Dieijen G, Comfurius P, Zwaal RFA. The role of activated human platelets in prothrombin and factor X activation. Blood 1985; 65: 31932.
  • 17
    Sims PJ, Wiedmer T. Unraveling the mysteries of phospholipid scrambling. Thromb Haemost 2001; 86: 26675.
  • 18
    Sulpice JC, Zachowski A, Devaux PF, Giraud F. Requirement for phosphatidylinositol 4,5-bisphosphate in the Ca2+-induced phospholipid redistribution in the human erythrocyte membrane. J Biol Chem 1994; 269: 634754.
  • 19
    Sulpice JC, Moreau C, Devaux PF, Zachowski A, Giraud F. Antagonist effects of Ca2+ and spermine on phosphatidylinositol 4,5-bisphosphate-mediated transmembrane redistribution of phospholipids in large unilamellar vesicles and in erythrocytes. Biochemistry 1996; 35: 1334552.
  • 20
    Bucki R, Giraud F, Sulpice JC. Phosphatidylinositol 4,5-bisphosphate domain inducers promote phospholipid transverse redistribution in biological membranes. Biochemistry 2000; 39: 583844.
  • 21
    Shiffer KA, Rood L, Emerson RK, Kuypers FA. Effects of phosphatidylinositol diphosphate on phospholipid asymmetry in the human erythrocyte membrane. Biochemistry 1998; 37: 344958.
  • 22
    Bucki R, Janmey PA, Vagners R, Giraud F, Sulpice JC. Involvement of phosphatidylinositol 4,5-bisphosphate in phosphatidylserine exposure in platelets: use of a permeant phosphoinositide-binding peptide. Biochemistry 2001; 25: 1575261.
  • 23
    Bevers EM, Wiedmer T, Comfurius P, Zhao J, Smeets EF, Schlegel RA, Schroit AJ, Weiss HJ, Williamson P, Zwaal RF, Sims PJ. The complex of phosphatidylinositol 4,5-bisphosphate and calcium ions is not responsible for Ca(2+)-induced loss of phospholipid asymmetry in the human erythrocyte: a study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling. Blood 1995; 86: 19839.
  • 24
    Wiedemann C, Schafer T, Burger MM. Chromaffin granule-associated phosphatidylinositol 4-kinase activity is required for stimulated secretion. EMBO J 1996; 15: 2094101.
  • 25
    Rogers KL, Grice ID, Griffiths LR. Inhibition of platelet aggregation and 5-HT release by extracts of Australian plants used traditionally as headache treatments. Eur J Pharm Sci 2000; 9: 35563.
  • 26
    Pollock WK, Rink TJ, Irvine RF. Liberation of [3H]arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by ionomycin and collagen. Biochem J 1986; 235: 86977.
  • 27
    Andersen H, Greenberg DL, Fujikawa K, Xu W, Chung DW, Davie EW. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci USA 1999; 96: 1118993.
  • 28
    Żendzian-Piotrowska M, Bucki R, Górska M, Górski J. Diabetes affects phospholipid content in the nuclei of the rat liver. Horm Metab Res 2000; 32: 3869.
  • 29
    Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89: 242942.
  • 30
    Hegewald H. One-dimensional thin-layer chromatography of all known D-3 and D-4 isomers of phosphoinositides. Anal Biochem 1996; 242: 1525.
  • 31
    Sulpice JC, Gascard P, Journet E, Rendu F, Renard D, Poggioli J, Giraud F. The separation of [32P]inositol phosphates by ion-pair chromatography: optimization of the method and biological applications. Anal Biochem 1989; 179: 907.
  • 32
    Hartwig JH, Bokoch GM, Carpenter CL, Janmey PA, Taylor LA, Toker A, Stossel TP. Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 1995; 82: 64353.
  • 33
    Hinchliffe KA, Irvine RF, Divecha N. Aggregation-dependent, integrin-mediated increases in cytoskeletally associated PtdInsP2 (4,5) levels in human platelets are controlled by translocation of PtdIns 4-P 5-kinase C to the cytoskeleton. EMBO J 1996; 15: 651624.
  • 34
    Bouchard BA, Tracy PB. Platelet regulation of thrombin generation in cardiovascular disease. Ital Heart J 2001; 11: 81923.
  • 35
    Nunez D, Randon J, Gandhi C, Siafaka-Kapadai A, Olson MS, Hanahan DJ. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism. J Biol Chem 1990; 265: 183308.
  • 36
    Bryckaert MC, Rendu F, Tobelem G, Wasteson A. Collagen-induced binding to human platelets of platelet-derived growth factor leading to inhibition of P43 and P20 phosphorylation. J Biol Chem 1989; 264: 433641.
  • 37
    Freedman JE, Parker C, Li L, Perlman JA, Frei B, Ivanov V, Deak LR, Iafrati MD, Folts JD. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 2001; 103: 27928.
  • 38
    Mesaeli N, Tappia PS, Suzuki S, Dhalla NS, Panagia V. Oxidants depress the synthesis of phosphatidylinositol 4,5-bisphosphate in heart sarcolemma. Arch Biochem Biophys 2000; 382: 4856.
  • 39
    Oyama Y, Noguchi S, Nakata M, Okada Y, Yamazaki Y, Funai M, Chikahisa L, Kanemaru K. Exposure of rat thymocytes to hydrogen peroxide increases annexin V binding to membranes: inhibitory actions of deferoxamine and quercetin. Eur J Pharmacol 1999; 384: 4752.
  • 40
    Kagan VE, Fabisiak JP, Shvedova AA, Tyurina YY, Tyurin VA, Schor NF, Kawai K. Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis. FEBS Lett 2000; 477: 17.